Home › Compare › BTVRF vs JNJ

BTVRF vs JNJ: Dividend Comparison 2026

BTVRF yields 250000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BTVRF wins by $4.567699004441311e+30M in total portfolio value
10 years
BTVRF
BTVRF
● Live price
250000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.567699004441311e+30M
Annual income
$4,564,107,688,187,857,300,000,000,000,000,000,000.00
Full BTVRF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BTVRF vs JNJ

📍 BTVRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBTVRFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BTVRF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BTVRF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BTVRF
Annual income on $10K today (after 15% tax)
$21,250,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,879,491,534,959,678,500,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, BTVRF beats the other by $3,879,491,534,959,678,500,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BTVRF + JNJ for your $10,000?

BTVRF: 50%JNJ: 50%
100% JNJ50/50100% BTVRF
Portfolio after 10yr
$2.2838495022206556e+30M
Annual income
$2,282,053,844,093,928,700,000,000,000,000,000,000.00/yr
Blended yield
99.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BTVRF
No analyst data
Altman Z
-28.1
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BTVRF buys
0
JNJ buys
0
No recent congressional trades found for BTVRF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBTVRFJNJ
Forward yield250000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$4.567699004441311e+30M$20.0K ✓
Annual income after 10y$4,564,107,688,187,857,300,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$4.567463897060879e+30M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BTVRF vs JNJ ($10,000, DRIP)

YearBTVRF PortfolioBTVRF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$25,010,700$25,000,000.00$10,676$355.77+$25.00M → BTVRF
2$58,462,976,402$58,436,214,953.27$11,407$389.39+$58462.96M → BTVRF
3$127,722,124,784,416$127,659,569,399,665.92$12,198$426.53+$127722124.77M → BTVRF
4$260,784,910,907,288,130$260,648,248,233,768,800.00$13,056$467.62+$260784910907.28M → BTVRF
5$497,657,939,618,196,950,000$497,378,899,763,526,240,000.00$13,987$513.12+$497657939618196.94M → BTVRF
6$887,590,576,640,622,200,000,000$887,058,082,645,230,600,000,000.00$14,998$563.56+$887590576640622208.00M → BTVRF
7$1,479,547,418,610,237,200,000,000,000$1,478,597,696,693,231,600,000,000,000.00$16,098$619.52+$1.4795474186102372e+21M → BTVRF
8$2,305,052,548,351,757,200,000,000,000,000$2,303,469,432,613,844,500,000,000,000,000.00$17,295$681.69+$2.3050525483517572e+24M → BTVRF
9$3,356,370,330,330,650,300,000,000,000,000,000$3,353,903,924,103,914,000,000,000,000,000,000.00$18,599$750.82+$3.3563703303306504e+27M → BTVRF
10$4,567,699,004,441,311,000,000,000,000,000,000,000$4,564,107,688,187,857,300,000,000,000,000,000,000.00$20,022$827.78+$4.567699004441311e+30M → BTVRF

BTVRF vs JNJ: Complete Analysis 2026

BTVRF — Stock

BlueRush Inc., through its subsidiary BlueRush Digital Media Corp., provides software as a service based marketing and sales enablement platform that enables organizations to engage with their customers in Canada, the United States, and other countries of North America. The company offers IndiVideo, an interactive personalized video platform for capturing knowledge and data from customers' video interactions, and creating data-driven customer insights. It serves banking, mortgages, investments and retirement, insurance, healthcare, real estate, telecommunications, marketing agencies, utilities, and non-profits industries. The company was formerly known as BlueRush Media Group Corp. and changed its name to BlueRush Inc. in April 2018. BlueRush Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

Full BTVRF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BTVRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BTVRF vs SCHDBTVRF vs JEPIBTVRF vs OBTVRF vs KOBTVRF vs MAINBTVRF vs ABBVBTVRF vs MRKBTVRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.